Searchable abstracts of presentations at key conferences in endocrinology

ea0063oc1.5 | Calcium and Bone | ECE2019

Renal function in 711 patients with hypoparathyroidism during more than 4 years of therapy

Siggelkow Heide , Stamm Bettina , Stamm Niklas , Blaschke Martina , Gruszendorf Martin

Patients (pts) with hypoparathyroidism (HypoPT) are at risk to develop renal failure possibly caused by hypercalciuria and nephrocalcinosis. We retrospectively evaluated the data of 711 Patients with HypoPT in 3 endocrine centres in Germany.Methods: Records of 711 pts with HypoPT were reviewed. Patients were predominantly female (n=592, male: n=119; age 50.9±14.1 years, range 12 – 99 years). The following parameters were docum...

ea0049oc10.1 | Bone & Calcium Homeostasis | ECE2017

Treatment of 711 patients with hypoparathyroidism: a retrospective study in 3 German endocrine centres

Grussendorf Martin , Stamm Bettina , Stamm Niklas , Siggelkow Heide

Care of patients (pts.) with hypoparathyroidism (HypoPT) is a challenge, because pts. are usually not treated with the absent hormone, but with several forms of vitamine D. We retrospectively evaluated the data of pts. with HypoPT in three endocrine centres in Germany.Methods: Records of 711 pts. with HypoPT (Centre 1 (C1): n=381, C2: n=253, C3: n=77) were reviewed (female: 592, male: 119). The following data under treatment (t...

ea0090p484 | Thyroid | ECE2023

Normative Values for the Hypoparathyroidism Patient Questionnaire (HPQ28) in the General German Population

Blaschke Martina , Wilde Deborah , Schulz Maxi , Herrmann-Lingen Christoph , Siggelkow Heide

Introduction: Patients with hypoparathyroidism (hypoPT) suffer from a number of complaints and reduced quality of life (QoL) besides having serum values for disease-specific parameters in the target range. To be able to quantify symptoms in hypoPT patients we lately developed a disease-specific questionnaire, the Hypoparathyroidism patient questionnaire with 28 items (HPQ28). The aim of this study was to present normative values for the HPQ28.Methods: A ...

ea0056gp182 | Parathyroid | ECE2018

Use of a Disease-Characteristic Questionnaire identified pain and cramps and neuro-vegetative symptoms as significantly elevated and affected by Medication in mainly well-controlled hypoparathyroid patients

Wilde Deborah , Wilken Lara , Stamm Bettina , Heppner Christina , Leha Andreas , Herrmann-Lingen Christoph , Siggelkow Heide

Introduction: Hypoparathyroidism (hypoPT) is characterized by inadequately low circulating concentrations of parathyroid hormone (PTH) followed by low calcium and increased phosphate levels in the blood. Patients with hypoPT suffer from a number of complications and complaints including infections, neuro-psychiatric diseases, abnormal bone architecture impaired muscle function and reduced quality of life. Due to the complexity of the various clinical manifestations there is a ...

ea0063p1044 | Interdisciplinary Endocrinology 2 | ECE2019

Current medical care in women with Turner syndrome-retrospective data from five different specialist endocrinology centers in Germany

Kahlert Elin , Blaschke Martina , Janssen Onno E , Stahnke Nikolaus , Strik Dominika , Merkel Martin , Mann Alexander , Liesenkoetter Klaus-Peter , Siggelkow Heide

Introduction: Turner syndrome (TS) is characterized by the complete or partial loss of one X chromosome and associated with a wide range of clinical manifestations. The clinical appearance depends on the specific karyotype, which may include different mosaic forms. Main features of almost all the karyotypes are short stature and delayed or absent puberty. Adult women in particular are at high risk of developing cardiac complications, metabolic syndrome, increased liver enzyme ...

ea0049ep353 | Steroid metabolism + action | ECE2017

Genetic variations in the HSD11B1 gene in patients treated with glucocorticoids show associations with bone mineral density

Siggelkow Heide , Blaschke Martina , Armbrecht Gabriele , Thomasius Friederike , Bock Oliver , Tzvetkov Mladen , Gluer Claus-C , Felsenberg Dieter

Introduction: Physiological glucocorticoids play an essential role in bone formation but can cause osteoporosis if present in excess. The key enzyme converting inactive cortisone into the active cortisol and vice versa is 11-beta-hydroxy-steroid-dehydrogenase (11β-HSD1). We have reported that genetic variations in the HSD11B1 gene correlate with increased cortisol levels in dexamethasone suppression and with changes in bone mineral density (BMD) suggesting indivi...

ea0070aep148 | Bone and Calcium | ECE2020

Successful quantification of symptom load by a disease-specific questionnaire HPQ 40/28 and analysis of influencing biochemical parameters in patients with postsurgical hypoparathyroidism

Wilde Deborah , Wilken Lara , Stamm Bettina , Heppner Christina , Leha Andreas , Blaschke Martina , Herrmann-Lingen Christoph , Siggelkow Heide

In hypoparathyroidism (HypoPT), patients suffer severely from reduced quality of life. The complexity of HypoPT demands a disease-specific control instrument to characterize symptom load. We employed a newly developed disease-specifichypoparathyroid patient questionnaire (the HPQ 40/28) to investigate and quantify HypoPT patients’ complaints and contributing factors. In this cross-sectional, two-center study, patients with postsurgical HypoPT (n = 49) were m...

ea0063gp25 | Calcium and Bone 1 | ECE2019

Impact of chronic hypoparathyroidism on health-related quality of life, symptoms, employment, and relationships: findings from a 13-country patient survey

Bollerslev Jens , Bent-Ennakhil Nawal , Chen Kristina , Clarke Bart L , Dahl-Hansen Helen , Germak John , Gibson Katie , Glenister Elizabeth , Judge Davneet , Marelli Claudio , Siggelkow Heide

Significant knowledge gaps exist regarding the humanistic effects of hypoparathyroidism, a rare, debilitating disorder. We report results from a global survey to characterise the burden of hypoparathyroidism from the patient perspective. An anonymous survey was conducted in patients with uncontrolled chronic hypoparathyroidism (as determined by patients’ report of persistent symptoms and/or poorly controlled calcium levels as told by their physician) despite receiving con...

ea0070aep158 | Bone and Calcium | ECE2020

Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: European subanalysis of a global patient survey

Siggelkow Heide , Germak John , Marelli Claudio , Chen Kristina , Dahl-Hansen Helen , Glenister Elizabeth , Bent-Ennakhil Nawal , Judge Davneet , Mycock Katie , Clarke Bart L

Although chronic hypoparathyroidism is known to negatively affect health-related quality of life (HRQoL), burden of illness is less well defined in patients whose disease is not adequately controlled on conventional therapy. We report burden of illness for the European subset of a patient survey in 13 countries globally. 398 adults with chronic hypoparathyroidism not adequately controlled on conventional therapy (recruited by treating physician or patient association) complete...

ea0056p241 | Calcium & Vitamin D metabolism | ECE2018

Burden of illness among patients with chronic hypoparathyroidism not adequately controlled with standard therapy by self-perception

Siggelkow Heide , Clarke Bart L. , Dahl-Hansen Helen , Glenister Elizabeth , Judge Davneet , Bent-Ennakhil Nawal , Gibson Katie , Germak John , Chen Kristina , Marelli Claudio , Bollerslev Jens

Significant knowledge gaps exist regarding the humanistic effects of chronic hypoparathyroidism (HPT), a rare, debilitating condition. We provide interim results from a global survey conducted to characterise the burden associated with chronic HPT from the patient perspective. An anonymous, self-reported survey (online or paper) was conducted in patients with chronic HPT, not adequately controlled with standard therapy by self-perception, from 12 countries through physicians o...